A. Stewart

Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine.

Joe D. Cohen, O. Ofori-Anyinam, C. Ockenhouse, 2006, Vaccine.

Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area

Conor P. Cahill, M. Demoitié, L. Otieno, 2009, PloS one.

Common and Divergent Immune Response Signaling Pathways Discovered in Peripheral Blood Mononuclear Cell Gene Expression Patterns in Presymptomatic and Clinically Apparent Malaria

Nathan D. Wolfe, Donald S. Burke, A. Scott, 2006, Infection and Immunity.

A cross‐sectional study of malaria endemicity and health system readiness to deliver services in Kenya, Namibia and Senegal

C. Olsen, P. Masuoka, T. Koehlmoos, 2017, Health policy and planning.

Activation of γδ T Cells in Malaria: Interaction of Cytokines and a Schizont-Associated Plasmodium falciparum Antigen

S. Pichyangkul, D. Heppner, K. Yongvanitchit, 1997 .

Decrease in circulating CD25(hi)Foxp3(+) regulatory T cells following vaccination with the candidate malaria vaccine RTS,S.

M. Sedegah, Eileen D. Villasante, J. Epstein, 2016, Vaccine.

Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeys.

W. Ballou, Joe D. Cohen, S. Pichyangkul, 2004, The American journal of tropical medicine and hygiene.

SAFETY AND IMMUNOGENICITY OF RTS , S + TRAP MALARIA VACCINE , FORMULATED IN THE AS 02 A ADJUVANT SYSTEM , IN INFANT RHESUS MONKEYS

Joe D. Cohen, S. Pichyangkul, P. Tongtawe, 2004 .

Activation of gammadelta T cells in malaria: interaction of cytokines and a schizont-associated Plasmodium falciparum antigen.

S. Pichyangkul, D. Heppner, K. Yongvanitchit, 1997, The Journal of infectious diseases.